KROS - Keros Therapeutics  - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

KROS is currently covered by 9 analysts with an average price target of $34.78. This is a potential upside of $20.21 (138.71%) from yesterday's end of day stock price of $14.57.

Keros Therapeutics 's activity chart (see below) currently has 24 price targets and 55 ratings on display. The stock rating distribution of KROS is 89.47% BUY and 10.53% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 30.27% with an average time for these price targets to be met of 46.3 days.

Highest price target for KROS is $41, Lowest price target is $15, average price target is $28.33.

Most recent stock forecast was given by SRIKRIPA DEVARAKONDA from TRUIST on 09-Apr-2025. First documented stock forecast 04-May-2020.

Currently out of the existing stock ratings of KROS, 34 are a BUY (89.47%), 4 are a HOLD (10.53%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$25

$10.79 (75.93%)

$43

22 days ago
(09-Apr-2025)

0/6 (0%)

$14.67 (142.01%)

Buy

$40

$25.79 (181.49%)

$40

1 months ago
(01-Apr-2025)

1/13 (7.69%)

$30.45 (318.85%)

113

Buy

$26

$11.79 (82.97%)

$111

2 months 4 days ago
(27-Feb-2025)

1/3 (33.33%)

$15.06 (137.66%)

74

Buy

$15

$0.79 (5.56%)

$105

3 months 14 days ago
(17-Jan-2025)

5/12 (41.67%)

$4.14 (38.12%)

43

Hold

3 months 14 days ago
(17-Jan-2025)

0/1 (0%)

$41.46 (76.02%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is KROS (Keros Therapeutics ) average time for price targets to be met?

On average it took 46.3 days on average for the stock forecasts to be realized with a an average price target met ratio 30.27

Which analyst has the current highest performing score on KROS (Keros Therapeutics ) with a proven track record?

JOSEPH CATANZARO

Which analyst has the most public recommendations on KROS (Keros Therapeutics )?

Joseph Catanzaro works at PIPER SANDLER and has 9 price targets and 7 ratings on KROS

Which analyst is the currently most bullish on KROS (Keros Therapeutics )?

Thomas Smith with highest potential upside - $31.36

Which analyst is the currently most reserved on KROS (Keros Therapeutics )?

Julian Harrison with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?